...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Linkage between the mechanisms of thrombocytopenia and thrombopoiesis
【24h】

Linkage between the mechanisms of thrombocytopenia and thrombopoiesis

机译:血小板减少和血小板生成机制之间的联系

获取原文
获取原文并翻译 | 示例

摘要

Thrombocytopenia is defined as a status in which platelet numbers are reduced. Imbalance between the homeostatic regulation of platelet generation and destruction is 1 potential cause of thrombocytopenia. In adults, platelet generation is a 2-stage process entailing the differentiation of hematopoietic stem cells into mature megakaryocytes (MKs; known as megakaryopoiesis) and release of platelets from MKs (known as thrombopoiesis or platelet biogenesis). Until recently, information about the genetic defects responsible for congenital thrombocytopenia was only available for a few forms of the disease. However, investigations over the past 15 years have identified mutations in genes encoding >20 different proteins that are responsible for these disorders, which has advanced our understanding of megakaryopoiesis and thrombopoiesis. The underlying pathogenic mechanisms can be categorized as (1) defects in MK lineage commitment and differentiation, (2) defects in MK maturation, and (3) defect in platelet release. Using these developmental stage categories, we here update recently described mechanisms underlying megakaryopoiesis and thrombopoiesis and discuss the association between platelet generation systems and thrombocytopenia.
机译:血小板减少症定义为血小板数量减少的状态。血小板生成的稳态调节与破坏之间的不平衡是血小板减少症的潜在原因之一。在成年人中,血小板生成是一个分为两个阶段的过程,需要将造血干细胞分化为成熟的巨核细胞(MK;称为巨核细胞),并从MK中释放血小板(称为血小板生成或血小板生物发生)。直到最近,有关先天性血小板减少症的遗传缺陷的信息仅适用于该疾病的几种形式。但是,过去15年的研究发现,编码导致这些疾病的> 20种不同蛋白质的基因中存在突变,这使我们对巨核细胞生成和血小板生成有了更深入的了解。潜在的致病机制可归类为(1)MK谱系定型和分化的缺陷,(2)MK成熟的缺陷和(3)血小板释放的缺陷。使用这些发育阶段类别,我们在此更新最近描述的巨核细胞生成和血小板生成的机制,并讨论血小板生成系统与血小板减少症之间的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号